ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag big pharma immunology neuroscience

3D image of a neuron cell network with a red glow representing inflammation.
New Insight into Brain Inflammation Inspires New Hope for Epilepsy Treatment 
Deanna MacNeil, PhD | Jun 1, 2023 | 2 min read
Clinicians and researchers teamed up to investigate how inappropriate proinflammatory mechanisms contribute to the pathogenesis of drug-refractory epilepsy.
Researchers in George Church&rsquo;s lab modified wild type ADK proteins (left) in <em >E.coli</em>, furnishing them with an nonstandard amino acid (nsAA) meant to biocontain the resulting bacterial strain.
A Pioneer of The Multiplex Frontier
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
Cancer cell
Interrogating the Complexities of the Tumor Microenvironment
Alison Halliday, PhD, Technology Networks | May 19, 2023 | 5 min read
Gaining a better understanding of the dynamic and reciprocal interactions between cancer cells and the tumor microenvironment is essential for improving patient diagnosis and treatment.
Top 10 Innovations 2013
The Scientist | Dec 1, 2013 | 10+ min read
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
Week in Review, June 17–21
Jef Akst | Jun 21, 2013 | 4 min read
On the gene patent decision; a high-res human brain model; bats’ influence on moths mating calls; toxicants threaten brain health; platelet-driven immunity
Start It Up
Dan Cossins | Apr 1, 2013 | 8 min read
Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.
New Approaches to Discovery Push Research at Big Biotech
James Kling | May 24, 1998 | 6 min read
The biotechnology industry is among the biggest employers of life science professionals, with 140,000 employees generating $17.4 billion of revenue in 1997, according to an industry report by Ernst & Young LLP of Palo Alto, Calif. Since the birth of biotechnology in the 1970s, many of the seminal companies--such as Biogen and Genentech-- have matured into profitable or near- profitable companies. As these companies arose, venture capitalists fell in love with start-up biotechs in the 1980s
Antidepressant Approvals Could Herald New Era in Psychiatric Drugs
Bianca Nogrady | Oct 1, 2019 | 9 min read
The FDA has given the green light to the first major new classes of antidepressant therapies in decades, opening up new avenues for therapeutic development.
NEW York-New Jersey Life Science Nirvana
Ted Agres | Apr 11, 2004 | 7 min read
Love it or hate it, if you want to play in the big leagues, the New York-New Jersey region is the place to be. From prestigous universities, medical centers, and research hospitals in Manhattan and Long Island, to major pharmaceutical research and manufacturing facilities in New Jersey, the region's life sciences can be characterized by such words as power-house and blockbuster.New York City alone (Manhattan, Brooklyn, Queens, Staten Island, and the Bronx) boasts 25 academic research and medical
Those We Lost in 2018
Ashley Yeager | Dec 26, 2018 | 10+ min read
The scientific community said goodbye to a number of leading researchers this year.

Run a Search

ADVERTISEMENT